Development of High Affinity Selective VIP1 Receptor Agonists
- 1 January 1997
- Vol. 18 (10), 1539-1545
- https://doi.org/10.1016/s0196-9781(97)00228-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The Long-Acting Vasoactive Intestinal Polypeptide Agonist RO 25-1553 Is Highly Selective of the VIP 2 Receptor SubclassPeptides, 1997
- Effect of introduction of an Arginine16 in VIP, PACAP and secretin on ligand affinity for the receptorsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
- Pharmacological properties of two recombinant splice variants of the PACAP type I receptor, transfected and stably expressed in CHO cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Properties of the VIP-PACAP type II receptor stably expressed in CHO cellsRegulatory Peptides, 1994
- Human Intestinal VIP Receptor: Cloning and Functional Expression of Two cDNA Encoding Proteins with Different N-Terminal DomainsBiochemical and Biophysical Research Communications, 1994
- The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- Amino acid sequence of VIP, PHI and secretin from the rabbit small intestinePeptides, 1990
- Differential effects of N-terminal modifications on the biological potencies of growth hormone releasing factor analogs with varying chain lengthsJournal of Medicinal Chemistry, 1986
- Potent stimulation of the avian exocrine pancreas by porcine and chicken vasoactive intestinal peptide.The Journal of Physiology, 1979
- Synthesis and some pharmacological properties of the 23-peptide 15-lysine-secretin-(5-27). Special role of the residue in position 15 in biological activity of the vasoactive intestinal polypeptideJournal of Medicinal Chemistry, 1978